Drug Elimination by Renal Route: Tubular Reabsorption

Highly permeable lipophilic and nonionized drugs undergo passive reabsorption from the tubular fluid into peritubular capillaries as the glomerular filtrate reaches the distal convoluted tubule. This reabsorption process significantly limits their renal excretion and reduces their elimination from the body through the kidneys.

The ionization of weak acids and weak bases is pH-dependent. When urine becomes alkaline, weakly acidic drugs become predominantly ionized. Conversely, acidifying urine ionizes weakly basic drugs. Since ionized forms are less permeable through tubular cells, they remain in the lumen and are excreted rather than reabsorbed.

Ion trapping is a mechanism where manipulating urine pH ionizes drugs, preventing their reabsorption. Ionized drug forms have reduced permeability through tubular cells, so they remain trapped in the tubular lumen and are eventually excreted in urine. This process increases renal clearance of undesirable drugs by blocking their back diffusion into peritubular capillaries.

Phenobarbital is a weak acid drug that undergoes reabsorption in the renal tubule. Bicarbonate alkalinizes the urine, ionizing the phenobarbital and preventing its back diffusion into the bloodstream. This ion trapping mechanism enhances renal elimination of the drug, reducing its toxicity and accelerating its clearance from the body.

Amphetamines are weakly basic drugs that are reabsorbed when in nonionized form. Acidifying the urine converts amphetamines to their ionized form, which cannot permeate tubular cells. The ionized drug remains in the lumen and is excreted, preventing reabsorption and increasing renal clearance to counteract overdose toxicity.

Most drugs are weak acids or weak bases whose ionization depends on urine pH. Unlike highly lipophilic nonionized drugs that are readily reabsorbed, ionized forms have low membrane permeability. By controlling urine pH, clinicians can manipulate drug ionization to either promote reabsorption or prevent it through ion trapping, depending on therapeutic goals.

Drug permeability through tubular cells directly determines reabsorption rates. Highly permeable lipophilic and nonionized drugs are readily reabsorbed into peritubular capillaries, limiting renal excretion. Ionized drugs have low permeability and remain in the tubular lumen. This permeability difference is exploited clinically by altering urine pH to control drug elimination.